Literature DB >> 8073950

Chemoimmunoconjugates for the treatment of cancer.

G A Pietersz1, A Rowland, M J Smyth, I F McKenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8073950     DOI： 10.1016/s0065-2776(08)60455-1

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  4 in total

Review 1.  Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

Authors:  Alexander Koshkaryev; Rupa Sawant; Madhura Deshpande; Vladimir Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2012-09-03       Impact factor: 15.470

Review 2.  Passive and active vaccination strategies to prevent ricin poisoning.

Authors:  Seth H Pincus; Joan E Smallshaw; Kejing Song; Jody Berry; Ellen S Vitetta
Journal:  Toxins (Basel)       Date:  2011-09-15       Impact factor: 4.546

3.  Mathematical and experimental analysis of localization of anti-tumour antibody-enzyme conjugates.

Authors:  T L Jackson; S R Lubkin; N O Siemers; D E Kerr; P D Senter; J D Murray
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

Review 4.  Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates.

Authors:  Dowdy Jackson; David Stover
Journal:  Pharm Res       Date:  2014-10-23       Impact factor: 4.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.